NASDAQ · Analyst Forecast

United Therapeutics Corporation (UTHR) Stock Forecast & Price Target

$585.89 NASDAQ: UTHR Market Cap $24.95B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering United Therapeutics Corporation (UTHR), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For United Therapeutics Corporation, analysts forecast revenue rising from $3.20B in 2025 to $5.91B in 2030; the average estimate for 2030 earnings per share is $51.24; with published estimates ranging from $41.76 to $58.93; 11 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$585.89
Consensus targetThe average of the price targets analysts have published.$669.40
Median targetThe middle target, less affected by a single outlier.$711.50
Highest targetThe most optimistic published target.$850.00
Lowest targetThe most pessimistic published target.$368.00
Difference from priceHow far the consensus target sits from today’s price.+14.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$3.16B$3.20B$3.25B10
2026$3.19B$3.25B$3.30B10
2027$3.37B$3.62B$4.11B11
2028$2.86B$4.11B$4.92B11
2029$4.25B$4.95B$5.52B5
2030$5.07B$5.91B$6.59B5

Earnings per share forecast

YearLowAverageHighAnalysts
2025$26.29$27.48$28.6510
2026$21.86$24.65$27.1810
2027$24.88$29.78$37.3811
2028$16.89$34.40$43.4811
2029$35.14$43.12$49.595
2030$41.76$51.24$58.935

United Therapeutics Corporation (UTHR) forecast — frequently asked questions

What is the analyst price target for United Therapeutics Corporation?

Analysts covering United Therapeutics Corporation (UTHR) have a consensus price target of $669.40, 14.3% above the current price of $585.89. Published targets range from $368.00 to $850.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for United Therapeutics Corporation's earnings?

The average analyst estimate for United Therapeutics Corporation (UTHR) earnings per share in 2030 is 51.24, with individual estimates between 41.76 and 58.93.

How much revenue is United Therapeutics Corporation expected to make?

Analysts forecast United Therapeutics Corporation (UTHR) revenue of $5.91B in 2030, based on 5 published estimates.

How many analysts cover UTHR?

11 analysts contribute estimates for United Therapeutics Corporation (UTHR). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastINCY forecastALNY forecastASND forecastEXEL forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.